PatientsLikeMe and Shire plc (LSE: SHP, NASDAQ: SHPG) have announced a new collaboration that will support the development of a patient-centered, real world health learning system that expands understanding of patient health and disease. Shire, the global leader in rare diseases and other highly specialized conditions, will work with PatientsLikeMe to appropriately engage patients and caregivers at every stage of their journey.
Allscripts (NASDAQ:MDRX) announced today that its Community interoperability platform, dbMotion Solution, is now available through the cloud via Microsoft Azure. The cloud-based solution offers the same capabilities as the on-premise version but the subscription model will enable faster implementation of the interoperability service and lower annual upgrade cost helping organizations to leverage the technology with less dependence on internal IT resources.
PR and marketing agency Highland Marketing has appointed Lyn Whitfield to the new post of strategy and content director. Whitfield is a journalist by background, who has specialised in writing about and working for the public sector and the NHS, and the IT companies who are seeking to digitise healthcare.
The U.S. Food and Drug Administration today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions. These are the first direct-to-consumer (DTC) tests authorized by the FDA that provide information on an individual's genetic predisposition to certain medical diseases or conditions, which may help to make decisions about lifestyle choices or to inform discussions with a health care professional.
As many healthcare organizations continue to face a shortage of highly skilled critical care nurses and intensivists, telemedicine has become a crucial element in caring for critically ill patients regardless of location. New data shows Royal Philips (NYSE: PHG, AEX: PHIA), a leading global health technology company, has helped Emory Healthcare to exceed their goals for streamlining the system's ICUs via use of population health solutions.
4 - 6 April 2017, Stuttgart, Germany.